A study for a 53 year old woman who takes Lamotrigine, Methylin - from FDA reports


Summary

97 females aged 53 (±5) who take the same drugs are studied. This is a personalized study for a 53 year old female patient who has Bipolar, Adhd. The study is created by eHealthMe based on reports from FDA.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>


On Jul, 22, 2017

97 females aged 53 (±5) who take Lamotrigine, Methylin are studied.


Number of reports submitted per year:

Lamotrigine, Methylin for a 53-year old woman.

Information of the patient in this study:

  • Age: 53
  • Gender: female
  • Conditions: Bipolar, Adhd
  • Drugs taken:
    • Lamotrigine (lamotrigine)
    • Methylin (methylphenidate hydrochloride)

eHealthMe real world results:

Most common drug interactions over time

< 1 month:
  • drug hypersensitivity
  • dermatitis bullous
  • high blood pressure
  • dry mouth
  • rheumatoid arthritis
  • glossodynia
  • thirst
  • appetite - decreased
1 - 6 months:
  • memory loss
  • balance disorder
  • rashes
  • weakness
  • headache
  • systemic lupus erythematosus
  • periodontal disease
  • endometrial atrophy
  • nausea
  • coordination abnormal
6 - 12 months:
  • therapeutic response unexpected
  • suicidal ideation
  • pre-existing condition improved
1 - 2 years:
  • atrioventricular block complete
  • dizziness (excl vertigo)
  • chest pain
  • fatigue
  • sensation of heaviness
  • sick sinus syndrome
  • heart rate decreased
  • nausea
2 - 5 years:
  • rashes
  • movement - uncoordinated
  • osteoporosis
  • swollen tongue
  • osteopenia
  • cataract
  • kyphosis
  • back pain
  • disturbance in attention
  • weight decreased
5 - 10 years:
n/a
10+ years:
  • weight decreased
  • kyphosis
  • osteopenia
  • cataract
  • back pain
  • disturbance in attention
  • arthritis
  • bone disorder
  • impaired driving ability
  • psychomotor hyperactivity
not specified:
  • memory loss
  • headache
  • back pain
  • osteopenia
  • weight decreased
  • injection site pain
  • fatigue
  • balance disorder
  • fall
  • rashes

Top conditions involved for these people *:

  • Narcolepsy (12 people, 12.37%)
  • Osteoporosis (10 people, 10.31%)
  • Insomnia (9 people, 9.28%)
  • Back Pain (8 people, 8.25%)
  • Crohn's Disease (7 people, 7.22%)

Top co-used drugs for these people *:

  • Synthroid (14 people, 14.43%)
  • Xyrem (13 people, 13.40%)
  • Neurontin (12 people, 12.37%)
  • Flexeril (12 people, 12.37%)
  • Ativan (12 people, 12.37%)

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

You can also:

Expand the study to include reports from both FDA and eHealthMe

Expand this study to include FDA and eHealthMe reports

What are the drugs?

What are the conditions?

Related studies:

Can you answer these questions?

More questions for: Methylin, Bipolar, Lamotrigine, Adhd

You may be interested in these reviews

More reviews for: Methylin, Bipolar, Lamotrigine, Adhd